Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: A prespecified substudy of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA) trial

Graeme Hankey; W. Hacke; D. Easton; S.C. Johnston; J-L. Mas; D.M. Brennan; D.L. Bhatt; K.A.A. Fox; E.J. Topol

doi:10.1161/STROKEAHA.110.586727

Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: A prespecified substudy of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA) trial

Graeme Hankey, W. Hacke, D. Easton, S.C. Johnston, J-L. Mas, D.M. Brennan, D.L. Bhatt, K.A.A. Fox, E.J. Topol

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	1679-1683
Journal	Stroke
Volume	41
DOIs	https://doi.org/10.1161/STROKEAHA.110.586727
Publication status	Published - 2010

Access to Document

10.1161/STROKEAHA.110.586727

Cite this

Hankey, G., Hacke, W., Easton, D., Johnston, S. C., Mas, J-L., Brennan, D. M., Bhatt, D. L., Fox, K. A. A., & Topol, E. J. (2010). Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: A prespecified substudy of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA) trial. Stroke, 41, 1679-1683. https://doi.org/10.1161/STROKEAHA.110.586727

Hankey, Graeme ; Hacke, W. ; Easton, D. ; Johnston, S.C. ; Mas, J-L. ; Brennan, D.M. ; Bhatt, D.L. ; Fox, K.A.A. ; Topol, E.J. / Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: A prespecified substudy of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA) trial. In: Stroke. 2010 ; Vol. 41. pp. 1679-1683.

@article{09a818de0dc241dbbfb52eee38667726,

title = "Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: A prespecified substudy of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA) trial",

author = "Graeme Hankey and W. Hacke and D. Easton and S.C. Johnston and J-L. Mas and D.M. Brennan and D.L. Bhatt and K.A.A. Fox and E.J. Topol",

year = "2010",

doi = "10.1161/STROKEAHA.110.586727",

language = "English",

volume = "41",

pages = "1679--1683",

journal = "Stroke",

issn = "0039-2499",

publisher = "Lippincott Williams & Wilkins",

}

Hankey, G, Hacke, W, Easton, D, Johnston, SC, Mas, J-L, Brennan, DM, Bhatt, DL, Fox, KAA & Topol, EJ 2010, 'Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: A prespecified substudy of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA) trial', Stroke, vol. 41, pp. 1679-1683. https://doi.org/10.1161/STROKEAHA.110.586727

Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: A prespecified substudy of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA) trial. / Hankey, Graeme; Hacke, W.; Easton, D.; Johnston, S.C.; Mas, J-L.; Brennan, D.M.; Bhatt, D.L.; Fox, K.A.A.; Topol, E.J.

In: Stroke, Vol. 41, 2010, p. 1679-1683.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: A prespecified substudy of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA) trial

AU - Hankey, Graeme

AU - Hacke, W.

AU - Easton, D.

AU - Johnston, S.C.

AU - Mas, J-L.

AU - Brennan, D.M.

AU - Bhatt, D.L.

AU - Fox, K.A.A.

AU - Topol, E.J.

PY - 2010

Y1 - 2010

U2 - 10.1161/STROKEAHA.110.586727

DO - 10.1161/STROKEAHA.110.586727

M3 - Article

C2 - 20595658

VL - 41

SP - 1679

EP - 1683

JO - Stroke

JF - Stroke

SN - 0039-2499

ER -

Hankey G, Hacke W, Easton D, Johnston SC, Mas J-L, Brennan DM et al. Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: A prespecified substudy of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (CHARISMA) trial. Stroke. 2010;41:1679-1683. https://doi.org/10.1161/STROKEAHA.110.586727